Skip to main content

Table 1 Predictors of death at five years for cervical cancer patients in Botswana who initiated curative chemoradiation treatment

From: Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana

Variable

Univariate

Multivariate

HR

95% CI

HR

95% CI

HIV

 Uninfected

Reference

   

 Infected

1.101311

.6339304  1.913278

1.250879

.657968  2.378075

Stage

 IA IB

Reference

   

 IIA IIB

3.229473

.991521  10.51868

2.72587

.802824  9.255287

 IIIA IIIB IV

4.204608

1.255063  14.08593

3.747349

1.08663  12.9231

Age

 <40

Reference

   

 40-59

1.225026

.6760837  2.219677

1.617596

.8523011  3.070061

 >60

1.445736

.6559022  3.186681

1.953187

.8017136  4.758482

Baseline Hb

 ≤10

Reference

   

 >10

0.4893405

.292142  .8196497

0.4624402

.256955  .8322505

Chemo cycles

 1

2.442394

1.191725  5.005592

1.992836

.9455122  4.200256

 2

1.039553

.4325541  2.498349

0.7922305

.3125914  2.007826

 3

1.202074

.6371535  2.26787

1.269207

.659052  2.444246

 ≥4

Reference

   

Final EQD2

 <75

Reference

   

 ≥75

1.011468

.9875201  1.035996

1.01332

.9895877  1.037622

Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us